Tithi Biswas, MD

This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvalumab works better than the usual care treatment…

Investigator

Tithi Biswas

Status

Accepting Candidates

Ages

18 Years - N/A

Sexes

All